VIR - Vir Biotechnology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
1,580,472
1,580,472
1,087,068
67,245
711
Cost of Revenue
146,319
146,319
65,865
-
-
Gross Profit
1,434,153
1,434,153
1,021,203
-
-
Operating Expenses
Research Development
474,648
474,648
448,006
302,411
148,472
Selling General and Administrative
161,762
161,762
160,793
70,937
37,598
Total Operating Expenses
601,085
601,085
600,452
364,225
178,690
Operating Income or Loss
833,068
833,068
420,751
-296,980
-177,979
Total Other Income/Expenses Net
-106,880
-106,880
128,612
-4,467
-5,061
Income Before Tax
754,280
754,280
549,802
-298,611
-174,529
Income Tax Expense
238,443
238,443
21,218
54
154
Income from Continuing Operations
515,837
515,837
528,584
-298,665
-174,683
Net Income
515,837
515,837
528,584
-298,665
-174,683
Net Income available to common shareholders
515,837
515,837
528,584
-298,665
-174,683
Basic EPS
-
-
4.07
-2.51
-5.76
Diluted EPS
-
-
3.96
-2.51
-5.76
Basic Average Shares
-
-
129,885
119,159
30,350
Diluted Average Shares
-
-
133,437
119,159
30,350
EBITDA
-
833,068
420,751
-296,980
-177,979